FilingSEC EDGAR8-K
iBio Approves Authorized Share Increase and Incentive Plan Amendment
· SEC accepted
StageApproval Granted
Filing content
Stockholders approved an increase in authorized common stock to 500 million shares and an amendment to the 2023 Omnibus Incentive Plan.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…